AI-based drug developer Basecamp valued at $800 million after $140 million funding round

3

By Puyaan Singh Sept 23 (Reuters) – Basecamp Research said on Wednesday it has raised $140 million in a Series C funding round that valued the AI-based drug developer at $800 million. The

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)